Bioharvest Sciences Inc (BHSC.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.9500 unch (unch) 02/14/25 [CNSX]
N/A x N/A N/A x N/A
Post-market 7.9500 unch (unch) -
for Fri, Feb 14th, 2025
Fiscal Year End Date: 12/31
(Values in thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Depreciation Amortization | 840 | 712 | 389 | 288 | 324 |
Accounts receivable | -22 | -588 | -266 | -73 | -36 |
Other Working Capital | 755 | -308 | -96 | -232 | 674 |
Other Operating Activity | -10,095 | -9,057 | -6,821 | -3,858 | -3,345 |
Operating Cash Flow | $-8,522 | $-9,241 | $-6,794 | $-3,875 | $-2,383 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,474 | -1,256 | -1,640 | -173 | -34 |
Investing Cash Flow | $-1,474 | $-1,256 | $-1,640 | $-173 | $-34 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 0 | -55 | -34 |
Debt Issued | 13,517 | 7,658 | 0 | 769 | 1,731 |
Debt Repayment | -364 | -359 | -332 | -257 | -317 |
Common Stock Issued | N/A | 0 | 7,466 | 4,469 | 742 |
Other Financing Activity | 403 | 839 | 3,638 | 0 | 0 |
Financing Cash Flow | $13,556 | $8,138 | $10,772 | $4,926 | $2,122 |
Exchange Rate Effect | 59 | -22 | -4 | -6 | 7 |
Beginning Cash Position | 1,736 | 4,117 | 1,783 | 911 | 1,199 |
End Cash Position | 5,355 | 1,736 | 4,117 | 1,783 | 911 |
Net Cash Flow | $3,560 | $-2,359 | $2,338 | $878 | $-295 |
Free Cash Flow | |||||
Operating Cash Flow | -8,522 | -9,241 | -6,794 | -3,875 | -2,383 |
Capital Expenditure | -1,474 | -1,256 | -1,640 | -173 | -34 |
Free Cash Flow | -9,996 | -10,497 | -8,434 | -4,048 | -2,417 |